(Q36392694)

13 August 2017

1 reference

title

Aldosterone--a hormone of cardiovascular adaptation and maladaptation (English)

1 reference

13 August 2017

author name string

Theodore L Goodfriend

series ordinal

1

1 reference

13 August 2017

publication date

1 February 2006

1 reference

Journal of Clinical Hypertension

13 August 2017

published in

1 reference

13 August 2017

volume

8

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

133-139

1 reference

New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

A quick glance at rapid aldosterone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

Aldosterone blockade in patients with systolic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

Relations between cardiac and vascular structure in patients with primary and secondary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2006.05110.X

10.1111/J.1524-6175.2006.05110.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference